Skip to main content
. 2018 Mar 7;15(5):7362–7368. doi: 10.3892/ol.2018.8189

Figure 3.

Figure 3.

Correlation between UBE2A and TNM stage in HCC patients. (A) Representative hematoxylin and eosin staining of TNM stage I and IV HCC tissues (scale bar, 100 µm) and (B) representative immunohistochemical staining of UBE2A in patients with TNM stage I and IV HCC (scale bar, 100 µm). (C) Immunohistochemical scores of UBE2A expression in HCC patients with different TNM stages. ****P<0.0001. UBE2A, ubiquitin-conjugating enzyme E2A; HCC, hepatocellular carcinoma.